TBMED aimed to support med-tech companies in the development of high-risk medical devices by reducing their time-to-market for the European sector.
TBMED helped European SMEs to maintain their competitiveness and innovation capacity in the face of global competition, e.g. from larger providers. Its aim was to minimise time-to-market and efforts for reimbursement and make medical devices accessible to patients more easily.
Facts and Figures
Duration
4 years
13 Partners
4 Countries
Funding
8.5 M €